Top compounds associated with response to USP17L30


Feature Type Standardized
Nominal ANOVA
mRNA silmitasertib CTRPv2 pan-cancer AAC -0.0079 0.8
mRNA BRD-K37390332 CTRPv2 pan-cancer AAC -0.008 0.8
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC 0.0068 0.8
mRNA Vandetanib CTRPv2 pan-cancer AAC 0.0073 0.8
mRNA KHS101 CTRPv2 pan-cancer AAC -0.0074 0.8
mRNA Teniposide CTRPv2 pan-cancer AAC -0.0079 0.8
mRNA KU-0063794 CTRPv2 pan-cancer AAC -0.0069 0.8
mRNA JQ-1:UNC0638 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.0067 0.8
mRNA brivanib CTRPv2 pan-cancer AAC 0.0069 0.8
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC 0.01 0.8
Download CSV